.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Furosemide - Generic Drug Details

« Back to Dashboard
Furosemide is the generic ingredient in two branded drugs marketed by Sun Pharm Inds, Fresenius Kabi Usa, Watson Labs, Abraxis Pharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Astrazeneca, Dava Pharms Inc, Marsam Pharms Llc, Organon Usa Inc, Warner Chilcott, Smith And Nephew, Roxane, Intl Medication, Emcure Pharms Ltd, Hospira, West-ward Pharms Int, Wockhardt, Claris, Sandoz, Amneal Pharms Co, Sun Pharm Inds Inc, Sanofi Aventis Us, Kalapharm, Wyeth Ayerst, Superpharm, Us Pharm Holdings, Luitpold, Mylan, Mutual Pharm, Leading Pharma Llc, Igi Labs Inc, and Vintage Pharms, and is included in sixty NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for furosemide. Sixty-four suppliers are listed for this compound.

Summary for Generic Name: furosemide

Tradenames:2
Patents:0
Applicants:33
NDAs:60
Drug Master File Entries: see list21
Suppliers / Packaging: see list64
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: furosemide

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
FUROSEMIDE
furosemide
TABLET;ORAL018569-005Aug 14, 1984RXNo► subscribe► subscribe
Wockhardt
FUROSEMIDE
furosemide
INJECTABLE;INJECTION077941-001Mar 22, 2007RXNo► subscribe► subscribe
Intl Medication
FUROSEMIDE
furosemide
TABLET;ORAL018753-001Feb 28, 1984DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: furosemide

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharm Holdings
LASIX
furosemide
TABLET;ORAL016273-001Approved Prior to Jan 1, 19824,324,779► subscribe
Sanofi Aventis Us
LASIX
furosemide
INJECTABLE;INJECTION016363-001Approved Prior to Jan 1, 19824,324,779► subscribe
Sanofi Aventis Us
LASIX
furosemide
SOLUTION;ORAL017688-001Approved Prior to Jan 1, 19824,324,779► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc